Sermorelin 8mg is a growth hormone support peptide used to stimulate natural growth hormone release, support IGF-1 activity, and align GH output more closely with the body’s normal pulsatile rhythm. It is for people who want a milder, more physiological GH-support option for recovery, sleep, body composition, and longer-term pituitary support. Supplied as an 8 mg cartridge in 2 mL, it provides a structured evening dosing format within The Clinic pen system.
How It Works
Sermorelin is a GHRH analogue that binds to the GHRH receptor in the anterior pituitary and stimulates the release of endogenous growth hormone in a pulsatile pattern. This supports downstream IGF-1 activity and makes Sermorelin a more physiological GH-axis option compared with direct hormone exposure. It is commonly used where the goal is to support natural GH signalling, recovery, sleep quality, and body-composition outcomes over time.
| Pathway |
Primary Effect |
| GHRH receptor |
Stimulates the pituitary to release natural growth hormone pulses |
| Growth hormone output |
Supports a more physiological GH release pattern |
| IGF-1 response |
Supports downstream anabolic and recovery-related signalling |
| Sleep-linked endocrine rhythm |
Pairs well with evening use to align with natural GH timing |
Results and Outcomes
Sermorelin is commonly used where the goal is improved GH-axis activity, a more natural rise in IGF-1, and broader support for recovery, sleep, and body composition. Its shorter pulse duration makes it a cleaner option for people who prefer a lighter, more physiologic GH-support approach rather than stronger or longer-acting secretagogues.
| Expected Outcome |
Practical Effect |
| Higher GH pulse activity |
Supports a more natural increase in endogenous GH release |
| Increased IGF-1 activity |
Supports downstream anabolic and metabolic signalling |
| Recovery support |
May help support recovery and tissue repair over time |
| Sleep support |
Evening use may align better with natural GH rhythm during sleep |
| Body-composition support |
May assist body-composition goals as part of a broader structured protocol |
Dosage Protocol
Total strength: 8 mg / 2 mL
Concentration: 4 mg/mL
Pen system: 200 units
Per unit: 40 mcg
Timing: Evening use
GH pulse duration triggered: 2–3 hours
Suggested Dosage Table
| Units |
Dose |
Volume |
| 8 units |
200 mcg |
0.08 mL |
| 10 units |
250 mcg |
0.10 mL |
| 12 units |
300 mcg |
0.12 mL |
| 14 units |
350 mcg |
0.14 mL |
| 16 units |
400 mcg |
0.16 mL |
Beginner Titration Protocol
| Phase |
Dose Range |
Pen Equivalent |
Timing |
| Week 1–2 (or 1–4) |
200–250 mcg |
8–10 units |
Evening |
| Week 3–4 (or 5–8) |
300 mcg |
12 units |
Evening |
| Week 5–6 (or 9–12) |
350–400 mcg |
14–16 units |
Evening |
Protocol Notes
| Guidance |
Detail |
| Evening use |
Use in the evening to better align with the body’s natural GH rhythm |
| Maintenance approach |
For longer-term maintenance, use the lowest effective dose for individual needs |
| Common maintenance range |
Many people find 250–300 mcg sufficient |
| Label-based escalation |
Start lower, then titrate upward only as needed |
Warnings
| Warning |
Detail |
| Use timing |
Use in the evening as directed by the protocol |
| Dose escalation |
Begin with the lower range before moving to higher doses |
| Maintenance dosing |
Use the lowest effective dose for ongoing use |
| Storage |
Keep refrigerated |
Related Products
| Product |
Use Case |
| Ipamorelin |
GH secretagogue pairing |
| Tesamorelin |
Stronger GHRH analogue option |
| CJC-1295 |
Alternative GH-axis support option |
| BPC-157 & TB-500 |
Recovery-focused pairing |
| MOTS-c |
Metabolic support pairing |
